Contrive Datum Insights_Logo.jpg
Update: The Global Klebsiella Testing Market Is Expected To Grow At A CAGR Of 7.1% During The Forecast Period.| Data By Contrive Datum Insights Pvt Ltd.
12 mai 2023 12h44 HE | Contrive Datum Insights Pvt Ltd
Farmington, May 12, 2023 (GLOBE NEWSWIRE) -- The Global Klebsiella Testing Market Is Expected To Grow At A CAGR Of 7.1% During The Forecast Period. Klebsiella infection is an infectious disease...
Contrive Datum Insights_Logo.jpg
The Global Klebsiella Testing Market Is Expected To Grow At A CAGR Of 7.1% During The Forecast Period.| Data By Contrive Datum Insights Pvt Ltd.
08 mai 2023 13h56 HE | Contrive Datum Insights Pvt Ltd
Farmington, May 08, 2023 (GLOBE NEWSWIRE) -- The Global Klebsiella Testing Market Is Expected To Grow At A CAGR Of 7.1% During The Forecast Period. Klebsiella infection is an infectious disease...
Lincoln-Health-Network.png
Medical Writing Landscape Advancement Summit Provides Unique Learning Opportunities to Improve Content Optimization
17 févr. 2021 09h35 HE | Lincoln Health Network
NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- via BioMedWire -- Lincoln Health Network, a leading conference production company focused on being the go-to source for thought leadership within the...
Lincoln-Health-Network.png
Clinical Document World Brings Thought Leaders, Innovative Approach to TMF, Inspection Readiness, Document Management, and Clinical Professionals
28 août 2020 09h35 HE | Lincoln Health Network
NEW YORK, Aug. 28, 2020 (GLOBE NEWSWIRE) -- via BioMedWire -- For clinical quality professionals seeking to improve processes through strategic improvements and partnerships, an exciting opportunity...
Lincoln-Health-Network.png
FWD Pharma Conference 2020 Provides Critical Digital Strategies to Biotech, Life Science Sectors
12 août 2020 09h35 HE | Lincoln Health Network
NEW YORK, Aug. 12, 2020 (GLOBE NEWSWIRE) -- via BioMedWire -- There’s an exciting buildup underway for the 2nd annual FWD Pharma Conference, slated to be held Aug. 31-Sept. 1, 2020. With a...
download.jpg
BrainStorm Issues 2019 Letter to Shareholders
18 déc. 2019 05h00 HE | BrainStorm Cell Therapeutics Inc.
NEW YORK, Dec. 18, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapeutics for neurodegenerative diseases, today issued a Letter to...
wscs14
San Antonio to Host 2014 World Stem Cell Summit
18 sept. 2013 17h04 HE | Genetics Policy Institute
SAN ANTONIO, Texas, Sept. 18, 2013 (GLOBE NEWSWIRE) -- Genetics Policy Institute (GPI), the producer of the annual World Stem Cell Summit, is announcing tonight at BioMed SA's 8th Annual Julio Palmaz...